Meltem Ayli (Meltem Aylı)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Clinical Practice

Hodgkin Lymphoma

Stem Cell Transplantation

Lipopolysaccharide Induced

Top Venues

Turkish journal of haematology : official journal of Turkish Society of Haematology

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Elif Gülsüm Ümit, Ahmet Muzaffer Demir, Muhlis Cem Ar, Mesut Ayer, Meltem Ayli, Volkan Karakus, Emin Kaya, Fahir Özkalemkaş, Nilgün Sayınalp, Mehmet Sonmez, Fahri Şahin, Selami Kocak Toprak, Tayfur Toptas, Irfan Yavasoglu, Ümran Çalış
Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (3) (2024)
Ahmet Muzaffer Demir, Elif Gülsüm Ümit, Muhlis Cem Ar, Mesut Ayer, Meltem Ayli, Volkan Karakus, Emin Kaya, Fahir Özkalemkaş, Nilgün Sayınalp, Mehmet Sonmez, Fahri Şahin, Selami Kocak Toprak, Tayfur Toptas, Irfan Yavasoglu, Ümran Çalış
Management of Adult Primary Immune Thrombocytopenia: Delphi-Based Consensus Recommendations Turkish journal of haematology : official journal of Turkish Society of Haematology 41 (2) (2024)
Olga Meltem Akay Yanar, Murat Özbalak, Mustafa Pehlivan, Birol Yildiz, Ant Uzay, Tuğçe Nur Yiğenoğlu, Tuğrul Elverdi, Leylagul Kaynar, Orhan Ayyildiz, Ipek Yonal Hindilerden, Hasan Sami Goksoy, Sebnem Izmir Guner, Ahmet Kursad Gunes, Mehmet Sonmez, Meltem Kurt Yüksel, Sinem Civriz Bozdag, Zübeyde Nur Özkurt, Tayfur Toptas, Mehmet Hilmi Dogu, Ozan Salim, Guray Saydam, Irfan Yavasoglu, Meltem Ayli, Gulsum Ozet, Murat Albayrak, Elif Birtaş Ateşoğlu, Selami Kocak Toprak, Rahsan Yildirim, Özgür Mehta, Sevgi Kalayoglu Besisik, Meliha Nalçacı, Fevzi Altuntas, Burhan Ferhanoğlu
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study. Hematological oncology 39 (4) (2021)